Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Papiris, K. Kagouridis, L. Kolilekas, A. Roussou, C. Triantafillidou, K. Baou, A. Papaporfyriou, G. Papadaki, K. Vougas, K. Malagari, S. Loukides, A. Kotanidou, A. Karakatsani, E. Manali (Athens, Greece). Survival in IPF acute exacerbations: The non-steroid approach. Eur Respir J 2013; 42: Suppl. 57, 463

Member's Comments

No comment yet.

Related content which might interest you: Outcome of acute drug-induced pneumonias in ICU Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Methotrexate reduces acute lung injury in a murine model of sepsis Source: International Congress 2016 – Infections, sepsis, and pulmonary embolism Year: 2016 Markers of poor outcome in patients with acute hypoxemic respiratory failure Source: International Congress 2014 – ICU outcomes, sepsis and infections Year: 2014 Helmet ventilation in AIDS patients with severe pneumonia and acute hypoxaemic respiratory failure Source: Annual Congress 2013 –NIV in the acute setting: growing experience and novel applications Year: 2013 Evaluation of nasal optiflow device in management of COPD patients in acute exacerbations Source: International Congress 2015 – Acute critical care: COPD, muscles and weaning Year: 2015 Effects of nebulized heparin on pulmonary inflammation in a rat model of acute lung injury Source: International Congress 2015 – Acute critical care: novelties in critical care Year: 2015 Preoperative statin administration does not protect against early postoperative acute respiratory distress syndrome (ARDS): A retrospective cohort study Source: Annual Congress 2013 –Acute respiratory failure, ARDS and severe COPD exacerbations Year: 2013 Drug-associated acute respiratory distress syndrome: A prospective observational cohort study Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Acute exacerbation in COPD: we must do more Source: Eur Respir J 2016; 47: 14-15 Year: 2016 Lung recruitment maneuver with and without nebulized albuterol for acute lung injury Source: International Congress 2014 – ARDS, skeletal muscles, physiology and weaning Year: 2014 Long-term effects of nebulized LPS in a mouse model of acute lung injury (ALI) Source: International Congress 2014 – ILDs 6 Year: 2014 Can procalcitonin or C-reactive protein predict supporative lung complications and ARDS at severe community-acquired pneumonia (CAP)? Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Acute phase reactants as predictors for hospital mortality in acute respiratory failure due to COPD exacerbation Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013 Left heart dysfunction in acute exacerbation of COPD: Only risk factor or even outcome? Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Dysfunction of oxidized pulmonary surfactant is cholesterol-dependent Source: Annual Congress 2013 –The multiple faces of stress in lung injury Year: 2013 Morbi-mortality evaluation in prolonged prone positioning during severe ARDS Source: International Congress 2015 – Acute critical care: novelties in critical care Year: 2015 Acute exacerbations of COPD Source: Eur Respir Monogr 2016; 74: 48-65 Year: 2016 Septic pulmonary embolisms as a cause of acute respiratory distress syndrome Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Acute exacerbations of chronic obstructive pulmonary disease: Is it acute exacerbations of chronic cardiopulmonary disease? Source: International Congress 2014 – Comorbidities Year: 2014 Acute exacerbations of interstitial lung disease Source: Eur Respir Monogr 2016; 74: 117-131 Year: 2016